Erratum: Modulation of tumorigenesis by the pro-inflammatory microRNA miR-301a in mouse models of lung cancer and colorectal cancer (Cell Discovery (2015) 1 (15005) DOI: 10.1038/celldisc.2015.5);Modulation of tumorigenesis by the pro-inflammatory microRNA miR-301a in mouse models of lung cancer and colorectal cancer

Cell Discovery

Volumn 1, Issue , 2015, Pages

  Ma, Xiaodong ^a,b,c   Yan, Fang ^d   Deng, Qipan ^b   Li, Fenge ^b   Lu, Zhongxin ^e   Liu, Mofang ^f   Wang, Lisheng ^g   Conklin, Daniel J ^b   McCracken, James ^b   Srivastava, Sanjay ^b   Bhatnagar, Aruni ^b   Li, Yong ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b University of Louisville School of Medicine   (United States)

^c SOUTH CHINA NORMAL UNIVERSITY   (China)

^d SOUTHERN MEDICAL UNIVERSITY   (China)

^e CENTRAL HOSPITAL OF WUHAN   (China)

^f INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^g JINAN UNIVERSITY   (China)

Author keywords

colon cancer; Kras; lung cancer; miR 301a; NF B; Stat3; tumor microenvironment

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 301A; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CANCER LOCALIZATION; CANCER MORTALITY; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DEXTRAN SULFATE SODIUM-INDUCED COLITIS; EMBRYO; IN VIVO STUDY; LUNG CARCINOGENESIS; MALE; MOUSE; NONHUMAN; ONCOGENE K RAS; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

EID: 84951729173     PISSN: None     EISSN: 20565968     Source Type: Journal    
DOI: 10.1038/celldisc.2016.22     Document Type: Erratum

References (51)

1. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140: 883-899.
2. Basseres DS, Ebbs A, Levantini E, Baldwin AS. Requirement of the NF-κB subunit p65/RelA for K-Rasinduced lung tumorigenesis. Cancer Res 2010; 70: 3537-3546.
3. Finco TS, Westwick JK, Norris JL, Beg AA, Der CJ, Baldwin AS Jr. Oncogenic Ha-Ras-induced signaling activates NF-κB transcriptional activity, which is required for cellular transformation. J Biol Chem 1997; 272: 24113-24116.
4. Takahashi H, Ogata H, Nishigaki R, Broide DH, Karin M. Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation. Cancer Cell 2010; 17: 89-97.
5. Greten FR, Eckmann L, Greten TF, et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118: 285-296.
6. Li Y, Du H, Qin Y, Roberts J, Cummings OW, Yan C. Activation of the signal transducers and activators of the transcription 3 pathway in alveolar epithelial cells induces inflammation and adenocarcinomas in mouse lung. Cancer Res 2007; 67: 8494-8503.
7. Grivennikov S, Karin E, Terzic J, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 2009; 15: 103-113.
8. Fukuda A, Wang SC, Morris JP, et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 2011; 19: 441-455.
9. Kortylewski M, Kujawski M, Wang T, et al. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med 2005; 11: 1314-1321.
10. Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 2009; 9: 798-809.
11. Lin W-W, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007; 117: 1175-1183.
12. Ma X, Becker Buscaglia LE, Barker JR, Li Y. MicroRNAs in NF-κB signaling. J Mol Cell Biol 2011; 3: 159-166.
13. Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 2010; 39: 493-506.
14. Mascaux C, Laes JF, Anthoine G, et al. Evolution of microRNA expression during human bronchial squamous carcinogenesis. Eur Resp J 2009; 33: 352-359.
15. Miko E, Czimmerer Z, Csánky E, et al. Differentially expressed micrornas in small cell lung cancer. Exp Lung Res 2009; 35: 646-664.
16. Du L, Schageman J, Irnov, et al. MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs. J Exp Clin Canc Res 2010; 29: 75.
17. Liu L, Nie J, Chen L, et al. The oncogenic role of microRNA-130a/301a/454 in human colorectal cancer via targeting Smad4 expression. PLoS One 2013; 8: e55532.
18. Cao G, Huang B, Liu Z, Zhang J, Xu H, Xia W, et al. Intronic miR-301 feedback regulates its host gene, ska2, in A549 cells by targeting MEOX2 to affect ERK/CREB pathways. Biochem Biophys Res Commun 2010; 396: 978-982.
19. Lu Z, Li Y, Takwi A, et al. miR-301a as an NF-kB activator in pancreatic cancer cells. EMBO J 2011; 30: 57-67.
20. Wang M, Li C, Yu B, et al. Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer. J Gastroenterol 2013; 48: 1023-1033.
21. Mycko MP, Cichalewska M, Machlanska A, Cwiklinska H, Mariasiewicz M, Selmaj KW. microRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination. Proc Natl Acad Sci USA 2012; 109: E1248-E1257.
22. Johnson L, Mercer K, Greenbaum D, et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 2001; 410: 1111-1116.
23. Shi W, Gerster K, Alajez NM, et al. MicroRNA-301 mediates proliferation and invasion in human breast cancer. Cancer Res 2011; 71: 2926-2937.
24. Lee H, Herrmann A, Deng JH, et al. Persistently activated Stat3 maintains constitutive NF-κB activity in tumors. Cancer Cell 2009; 15: 283-293.
25. Wang L, Walia B, Evans J, Gewirtz AT, Merlin D, Sitaraman SV. IL-6 induces NF-κB activation in the intestinal epithelia. J Immunol 2003; 171: 3194-3201.
26. Liang J, Nagahashi M, Kim EY, et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitisassociated cancer. Cancer Cell 2013; 23: 107-120.
27. Perše M, Cerar A. Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol 2012; 2012: 13.
28. Jemal A, Siegel R, Xu J, Ward E. Cancer Statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
29. Rosenberg DW, Giardina C, Tanaka T. Mouse models for the study of colon carcinogenesis. Carcinogenesis 2009; 30: 183-196.
30. Norris JL, Baldwin AS Jr. Oncogenic Ras enhances NF-κB transcriptional activity through Raf-dependent and Raf-independent mitogen-activated protein kinase signaling pathways. J Biol Chem 1999; 274: 13841-13846.
31. Kim BY, Gaynor RB, Song K, Dritschilo A, Jung M. Constitutive activation of NF-κB in Ki-ras-transformed prostate epithelial cells. Oncogene 2002; 21: 4490-4497.
32. Houghton AM. Mechanistic links between COPD and lung cancer. Nat Rev Cancer 2013; 13: 233-245.
33. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 526-535.
34. Yoshimura A. Signal transduction of inflammatory cytokines and tumor development. Cancer Sci 2006; 97: 439-447.
35. Grivennikov SI, Karin M. Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 2010; 21: 11-19.
36. Bollrath J, Greten FR. IKK/NF-κB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis. EMBO Rep 2009; 10: 1314-1319.
37. Numasaki M, Watanabe M, Suzuki T, et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol 2005; 175: 6177-6189.
38. Chae WJ, Gibson TF, Zelterman D, Hao L, Henegariu O, Bothwell AL. Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. Proc Natl Acad Sci USA 2010; 107: 5540-5544.
39. Hyun YS, Han DS, Lee AR, Eun CS, Youn J, Kim HY. Role of IL-17A in the development of colitisassociated cancer. Carcinogenesis 2012; 33: 931-936.
40. Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D, Yu H. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med 2009; 206: 1457-1464.
41. Kryczek I, Wei S, Szeliga W, Vatan L, Zou W. Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood 2009; 114: 357-359.
42. Huang L, Liu Y, Wang L, et al. Down-regulation of miR-301a suppresses pro-inflammatory cytokines in Tolllike receptor-triggered macrophages. Immunology 2013; 140: 314-322.
43. Li Q, Antwerp DV, Mercurio F, Lee K-F, Verma IM. Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 1999; 284: 321-325.
44. Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA 1997; 94: 3801-3804.
45. Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007; 129: 1401-1414.
46. Chiang HR, Schoenfeld LW, Ruby JG, et al. Mammalian microRNAs: experimental evaluation of novel and previously annotated genes. Genes Dev 2010; 24: 992-1009.
47. Froese N, Schwarzer M, Niedick I, Frischmann U, Köster M, Kröger A, et al. Innate immune responses in NF-kBrepressing factor-deficient mice. Mol Cell Biol 2006; 26: 293-302.
48. Suzuki R, Kohno H, Sugie S, Nakagama H, Tanaka T. Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice. Carcinogenesis 2006; 27: 162-169.
49. Ma X, Kumar M, Choudhury SN, et al. Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis. Proc Natl Acad Sci USA 2011; 108: 10144-10149.
50. Xu C, Inokuma MS, Denham J, et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechol 2001; 19: 971-974.
51. Weischenfeldt J, Porse B. Bone marrow-derived macrophages (BMM): isolation and applications. CSH protocols 2008; 2008: 1-6.